Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats

Biochemical and Biophysical Research Communications

Volumn 341, Issue 1, 2006, Pages 209-217

  Yang, Baichun ^a   Chen, Lihong ^a   Qian, Ying ^a   Triantafillou, James A ^a   McNulty, Judi A ^a   Carrick, Kevin ^a   Clifton, Lisa G ^a   Han, Bajin ^a   Geske, Robert ^a   Strum, Jay ^a   Brown, Kathleen K ^a   Stimpson, Stephen A ^a   Pahel, Greg ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Adiponectin; Insulin; Lipid; Liver; Muscle; Rat; White adipose tissue PPAR

Indexed keywords

ADIPONECTIN; FATTY ACID; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; GASTROCNEMIUS MUSCLE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ANIMALS; DIETARY FATS; DIETARY SUCROSE; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; OXAZOLES; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

ANIMALIA;

EID: 30944449424     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.172     Document Type: Article

References (44)

1. A.H. Berg, T.P. Combs, and P.E. Scherer ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism Trends Endocrinol. Metab. 13 2002 84 89
2. N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi, and Y. Matsuzawa Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat. Med. 8 2002 731 737
3. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, B.E. Bihain, and H.F. Lodish Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc. Natl. Acad. Sci. USA 98 2001 2005 2010
4. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, and T. Kadowaki The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat. Med. 7 2001 941 946
5. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat. Med. 8 2002 1288 1295
6. E. Tomas, T.S. Tsao, A.K. Saha, H.E. Murrey, C.C. Zhang, S.I. Itani, H.F. Lodish, and N.B. Ruderman Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation Proc. Natl. Acad. Sci. USA 99 2002 16309 16313
7. T.P. Combs, A.H. Berg, S. Obici, P.E. Scherer, and L. Rossetti Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 J. Clin. Invest. 108 2001 1875 1881
8. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Hanafusa, and Y. Matsuzawa Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler. Thromb. Vasc. Biol. 20 2000 1595 1599
9. K. Hotta, and Y. Matsuzawa Molecular mechanism in the development of the complications associated with obesity-the physiological and pathological role of adipocytokines Jpn. J. Clin. Med. 59 2001 481 486
10. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, and Y. Matsuzawa Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem. Biophys. Res. Commun. 257 1999 79 83
11. O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, S. Rahe, H. Staiger, E. Maerker, H. Haring, and M. Stumvoll Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism Diabetes 52 2003 239 243
12. Y. Yamamoto, H. Hirose, I. Saito, K. Nishikai, and T. Saruta Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population J. Clin. Endocrinol. Metab. 89 2004 87 90
13. F. Fumeron, R. Aubert, A. Siddiq, D. Betoulle, F. Péan, S. Hadjadj, J. Tichet, E. Wilpart, M. Chesnier, B. Balkau, P. Froguel, and M. Marre For the epidemiologic data on the insulin resistance syndrome (DESIR) study group: adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period. The epidemiologic data on the insulin resistance syndrome prospective study Diabetes 53 2004 1150 1157
14. B.B. Duncan, M.I. Schmidt, J.S. Pankow, H. Bang, D. Couper, C.M. Ballantyne, R.C. Hoogeveen, and G. Heiss Adiponectin and the development of type 2 diabetes the atherosclerosis risk in communities study Diabetes 53 2004 2473 2478
15. A.S. Lihn, T. Østergård, B. Nyholm, S.B. Pedersen, B. Richelsen, and O. Schmitz Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients Am. J. Physiol. Endocrinol. Metab. 284 2003 E443 E448
16. D.S. Lindsay, T. Funahashi, R.L. Hanson, Y. Matsuzawa, S. Tanaka, P.A. Tataranni, W.C. Knowler, and J. Krakoff Adiponectin and development of type 2 diabetes in the Pima Indian population Lancet 360 2002 57 58
17. B. Vozarova, N. Stefan, R.S. Lindsay, J. Krakoff, W.C. Knowler, T. Funahashi, Y. Matsuzawa, M. Stumvoll, C. Weyer, and P.A. Tataranni Low plasma adiponectin concentrations do not predict weight gain in humans Diabetes 51 2002 2964 2967
18. W. Yang, W. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, C. Chao, C. Chen, T. Tai, and L. Chuang Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin J. Clin. Endocrinol. Metab. 86 2001 3815 3819
19. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Hanafusa, and Y. Matsuzawa Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler. Thromb. Vasc. Biol. 20 2000 1595
20. K. Esposito, A. Pontillo, C.D. Palo, G. Giugliano, M. Masella, R. Marfella, and D. Giugliano Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. A randomized trial JAMA 289 2003 1799 1804
21. K. Harada, W.J. Shen, S. Patel, V. Natu, J. Wang, J. Osuga, S. Ishibashi, and F.B. Kraemer Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice Am. J. Physiol. Endocrinol. Metab. 285 2003 E1182 E1195
22. H.C. Chen, D.R. Jensen, H.M. Myers, R.H. Eckel, and R.V. Farese Jr. Obesity resistance and enhanced glucose metabolismin mice transplanted with white adipose tissue lacking acyl CoA:diacylglycerol acyltransferase 1 J. Clin. Invest. 111 2003 1715 1722
23. S. Blüher, M. Ziotopoulou, J.W. Bullen Jr., S.J. Moschos, L. Ungsunan, E. Kokkotou, E. Maratos-Flier, and C.S Mantzoros Responsiveness to peripherally administered melanocortins in lean and obese mice Diabetes 53 2004 82 90
24. L. Ma, S. Mao, K.L. Taylor, T. Kanjanabuch, Y. Guan, Y. Zhang, N.J. Brown, L.L. Swift, O.P. McGuinness, D.H. Wasserman, D.E. Vaughan, and A.B. Fogo Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1 Diabetes 53 2004 336 346
25. E.E. Kershaw, N.M. Morton, H. Dhillon, L. Ramage, J.R. Seckl, and J.S. Flier Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity Diabetes 54 2005 1023 1031
26. B. Yang, P. Lin, K.M. Carrick, J.A. McNulty, L.G. Clifton, D.A. Winegar, J.C. Strum, S.A. Stimpson, and G.L. Pahel PPARγ agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats Biochem. Biophys. Res. Commun. 334 2005 176 182
27. K. Hotta, T. Funahashi, N.L. Bodkin, H.K. Ortmeyer, Y. Arita, B.C. Hansen, and Y. Matsuzawa Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 50 2001 1126 1133
28. T.P. Combs, J.A. Wagner, J. Berger, T. Doebber, W.J. Wang, B.B. Zhang, M. Tanen, A.H. Berg, S. O'Rahilly, D.B. Savage, K. Chatterjee, S. Weiss, P.J. Larson, K.M. Gottesdiener, B.J. Gertz, M.J. Charron, P.E. Scherer, and D.E. Moller Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization Endocrinology 143 2002 998 1007
29. W.S. Yang, C.Y. Jeng, T.J. Wu, S. Tanaka, T. Funahashi, Y. Matsuzawa, J.P. Wang, C.L. Chen, T.Y. Tai, and L.M. Chuang Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients Diabetes Care 25 2002 376 380
30. American Diabetes Association, Physical activity/exercise and diabetes, Diabetes Care. 27 (2004) S58-S62.
31. E. Ravussin, and S.R. Smith Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus Ann. NY Acad. Sci. 967 2002 363 378
32. W.W. Winder Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle J. Appl. Physiol. 91 2001 1017 1028
33. B. Yang, L.G. Clifton, J.A. McNulty, L. Chen, K.K. Brown, and P.G. Baer Effects of a PPARgamma agonist, GI262570, on renal filtration fraction and nitric oxide level in conscious rats J. Cardiovasc. Pharmacol. 42 2003 436 441
34. T.M. Willson, M.H. Lambert, and S.A. Kliewer Peroxisome proliferation-activated receptor gamma and metabolic disease Annu. Rev. Biochem. 70 2001 341 367
35. J.M. Chirgwin, A.E. Przybyla, R.J. MacDonald, and W.J. Rutter Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease Biochemistry 18 1979 5294 5299
36. S. Bustin Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J. Mol. Endocrinol. 25 2000 169 193
37. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, and P.A. Tataranni Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J. Clin. Endocrinol. Metab. 86 2001 1930 1935
38. Y. Yamamoto, H. Hirose, I. Saito, M. Tomita, M. Taniyama, K. Matsubara, Y. Okazaki, T. Ishii, K. Nishikai, and T. Saruta Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population Clin. Sci. 103 2002 137 142
39. E.K. Naderali, D. Estadella, M. Rocha, L.C. Pickavance, S. Fatani, R.G. Denis, and G. Williams A fat-enriched, glucose-enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue Clin. Sci. 105 2003 403 408
40. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
41. T.S. Tsao, H.E. Murrey, C. Hug, D.H. Lee, and H.F. Lodish Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30) J. Biol. Chem. 277 2002 29359 29362
42. H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, S. Kita, K. Hara, Y. Hada, F. Vasseur, P. Froguel, S. Kimura, R. Nagai, and T. Kadowaki Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin J. Biol. Chem. 278 2003 40352 40363
43. f.f.M. Fisher, M.E. Trujillo, W. Hanif, A.H. Barnett, P.G. McTernan, P.E. Scherer, and S. Kumar Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males Diabetologia 48 2005 1084 1087
44. U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doebber, J.P. Berger, J.A. Wagner, M. Wu, A. Knopps, A.H. Xiang, K.M. Utzschneider, S.E. Kahn, J.M. Olefsky, T.A. Buchanan, and P.E. Scherer Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity J. Biol. Chem. 279 2004 12152 12162